These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 36766777)
41. Low-Level Vagus Nerve Stimulation Reverses Cardiac Dysfunction and Subcellular Calcium Handling in Rats With Post-Myocardial Infarction Heart Failure. Zhang Y; Chen A; Song L; Li M; Luo Z; Zhang W; Chen Y; He B Int Heart J; 2016 May; 57(3):350-5. PubMed ID: 27181040 [TBL] [Abstract][Full Text] [Related]
42. Protein kinase A type I and type II define distinct intracellular signaling compartments. Di Benedetto G; Zoccarato A; Lissandron V; Terrin A; Li X; Houslay MD; Baillie GS; Zaccolo M Circ Res; 2008 Oct; 103(8):836-44. PubMed ID: 18757829 [TBL] [Abstract][Full Text] [Related]
43. The antiapoptotic protein HAX-1 mediates half of phospholamban's inhibitory activity on calcium cycling and contractility in the heart. Bidwell PA; Haghighi K; Kranias EG J Biol Chem; 2018 Jan; 293(1):359-367. PubMed ID: 29150445 [TBL] [Abstract][Full Text] [Related]
44. Calcitriol modulation of cardiac contractile performance via protein kinase C. Green JJ; Robinson DA; Wilson GE; Simpson RU; Westfall MV J Mol Cell Cardiol; 2006 Aug; 41(2):350-9. PubMed ID: 16815434 [TBL] [Abstract][Full Text] [Related]
45. Enhanced cardiac function in Gravin mutant mice involves alterations in the β-adrenergic receptor signaling cascade. Guillory AN; Yin X; Wijaya CS; Diaz Diaz AC; Rababa'h A; Singh S; Atrooz F; Sadayappan S; McConnell BK PLoS One; 2013; 8(9):e74784. PubMed ID: 24058627 [TBL] [Abstract][Full Text] [Related]
46. HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization. Sivakumaran V; Stanley BA; Tocchetti CG; Ballin JD; Caceres V; Zhou L; Keceli G; Rainer PP; Lee DI; Huke S; Ziolo MT; Kranias EG; Toscano JP; Wilson GM; O'Rourke B; Kass DA; Mahaney JE; Paolocci N Antioxid Redox Signal; 2013 Oct; 19(11):1185-97. PubMed ID: 23919584 [TBL] [Abstract][Full Text] [Related]
47. Calcium regulatory proteins and their alteration by transgenic approaches. Dillmann WH Am J Cardiol; 1999 Jun; 83(12A):89H-91H. PubMed ID: 10750595 [TBL] [Abstract][Full Text] [Related]
48. Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart. Zhang Y; Wang WE; Zhang X; Li Y; Chen B; Liu C; Ai X; Zhang X; Tian Y; Zhang C; Tang M; Szeto C; Hua X; Xie M; Zeng C; Wu Y; Zhou L; Zhu W; Yu D; Houser SR; Chen X Circ Res; 2019 Jun; 124(12):1760-1777. PubMed ID: 30982412 [TBL] [Abstract][Full Text] [Related]
49. Cardiomyocytes from AKAP7 knockout mice respond normally to adrenergic stimulation. Jones BW; Brunet S; Gilbert ML; Nichols CB; Su T; Westenbroek RE; Scott JD; Catterall WA; McKnight GS Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17099-104. PubMed ID: 23035250 [TBL] [Abstract][Full Text] [Related]
51. Preserved cardiac function despite marked impairment of cAMP generation. Gao MH; Lai NC; Tang T; Guo T; Tang R; Chun BJ; Wang H; Dalton NN; Suarez J; Dillmann WH; Hammond HK PLoS One; 2013; 8(9):e72151. PubMed ID: 24147149 [TBL] [Abstract][Full Text] [Related]
52. KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signaling. Jin H; Hadri L; Palomeque J; Morel C; Karakikes I; Kaprielian R; Hajjar R; Lebeche D J Mol Cell Cardiol; 2010 Jun; 48(6):1169-79. PubMed ID: 20051248 [TBL] [Abstract][Full Text] [Related]
53. Ca(2+)-handling proteins and heart failure: novel molecular targets? Prestle J; Quinn FR; Smith GL Curr Med Chem; 2003 Jun; 10(11):967-81. PubMed ID: 12678683 [TBL] [Abstract][Full Text] [Related]
54. Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP). Rababa'h A; Craft JW; Wijaya CS; Atrooz F; Fan Q; Singh S; Guillory AN; Katsonis P; Lichtarge O; McConnell BK J Mol Biol; 2013 Sep; 425(18):3277-88. PubMed ID: 23806656 [TBL] [Abstract][Full Text] [Related]
55. A-kinase anchoring proteins: scaffolding proteins in the heart. Diviani D; Dodge-Kafka KL; Li J; Kapiloff MS Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1742-53. PubMed ID: 21856912 [TBL] [Abstract][Full Text] [Related]
56. Calcium cycling proteins and their association with heart failure. Hadri L; Hajjar RJ Clin Pharmacol Ther; 2011 Oct; 90(4):620-4. PubMed ID: 21832991 [TBL] [Abstract][Full Text] [Related]
57. Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C. Uys GM; Ramburan A; Loos B; Kinnear CJ; Korkie LJ; Mouton J; Riedemann J; Moolman-Smook JC BMC Cell Biol; 2011 May; 12():18. PubMed ID: 21569246 [TBL] [Abstract][Full Text] [Related]
58. A-kinase anchoring protein 5 anchors protein kinase A to mediate PLN/SERCA to reduce cardiomyocyte apoptosis induced by hypoxia and reoxygenation. Wang Z; Zhang X; Zhu F; Zhou S; Wang Q; Wang H Biochem Cell Biol; 2022 Apr; 100(2):162-170. PubMed ID: 35041539 [TBL] [Abstract][Full Text] [Related]
59. β-adrenergic effects on cardiac myofilaments and contraction in an integrated rabbit ventricular myocyte model. Negroni JA; Morotti S; Lascano EC; Gomes AV; Grandi E; Puglisi JL; Bers DM J Mol Cell Cardiol; 2015 Apr; 81():162-75. PubMed ID: 25724724 [TBL] [Abstract][Full Text] [Related]
60. Single nucleotide polymorphisms alter kinase anchoring and the subcellular targeting of A-kinase anchoring proteins. Smith FD; Omar MH; Nygren PJ; Soughayer J; Hoshi N; Lau HT; Snyder CG; Branon TC; Ghosh D; Langeberg LK; Ting AY; Santana LF; Ong SE; Navedo MF; Scott JD Proc Natl Acad Sci U S A; 2018 Dec; 115(49):E11465-E11474. PubMed ID: 30455320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]